Insider Transactions in Q4 2022 at Dexcom Inc (DXCM)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2022
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.3%
|
$46,144
$112.57 P/Share
|
|
Dec 08
2022
|
Paul R Flynn EVP Global Revenue |
SELL
Open market or private sale
|
Direct |
8,988
-13.88%
|
$1,105,524
$123.5 P/Share
|
|
Nov 21
2022
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,844
-5.32%
|
$430,528
$112.62 P/Share
|
|
Nov 21
2022
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,781
-5.78%
|
$423,472
$112.62 P/Share
|
|
Nov 21
2022
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,400
-3.45%
|
$268,800
$112.62 P/Share
|
|
Nov 08
2022
|
Girish Naganathan EVP Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,449
+50.0%
|
-
|
|
Nov 03
2022
|
Kevin R Sayer President CEO and Chairman |
SELL
Bona fide gift
|
Direct |
10,000
-2.55%
|
-
|